Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HSK21542 for moderate-to-severe pruritus in liver disease
CTR20211940Phase 2Completed
- Sponsor
- Liaoning Hisun Pharmaceutical
- Start
- Aug 2021
- Modality
- Small Molecules, Peptides
- Countries
- 1
01
Overview
A Phase 2 trial of hsk21542 in pruritus, sponsored by Liaoning Hisun Pharmaceutical. Started Aug 2021; status: completed.
02
Drugs
hsk21542
03
Conditions
pruritus
Beyond the preview
Go deeper on CTR20211940.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20211940.